Clinical Features of 69 Cases With Coronavirus Disease 2019 in Wuhan, China

Cited by (1,001)

Items 501–600 of 1,001

1. COVID-19 Emergency and Post-Emergency in Italian Cancer Patients: How Can Patients Be Assisted?
   Anna Crispo, Concetta Montagnese, Francesco Perri, Maria Grimaldi, Sabrina Bimonte, Livia S. A. Augustin, Alfonso Amore, Egidio Celentano, Marilena Di Napoli, Marco Cascella et al. · 2020 · Frontiers in Oncology
2. Epidemiological and Clinical Characteristics of Deceased COVID-19 Patients
   Mohammed Badedi, Hussain Ahmed Darraj, Awaji Alnami, Ali Mohammed Makrami, Mohamed Salih Mahfouz, Khalid A Alhazmi, Nahid Mahmoud, Halimh Ali Mosa · 2021 · International Journal of General Medicine
3. Coronavirus disease (COVID-19) complicated by rhino-orbital-cerebral mucormycosis presenting with neurovascular thrombosis: a case report and review of literature
   Vahid Reza Ostovan, Shirin Rezapanah, Zahra Behzadi, Leila Hosseini, Reza Jahangiri, Mohammad Hossein Anbardar, Mahtab Rostami · 2021 · Journal of NeuroVirology
4. Understanding the role of nACE2 in neurogenic hypertension among COVID-19 patients
   Prakash G. Kulkarni, Amul J. Sakharkar, Tanushree Banerjee · 2021 · Hypertension Research
5. Lessons Learned from COVID-19 Pandemic in Italy
   Antonio Minni, Massimo Ralli, Francesca Candelori, Fabrizio Cialente, Lucia Ercoli, Claudio Parlapiano, Antonio Greco, Marco DE VINCENTIIS · 2020 · Bosnian Journal of Basic Medical Sciences
6. Severe COVID-19 Cases: Is Respiratory Distress Partially Explained by Central Nervous System Involvement?
   Calixto Machado-Curbelo · 2020 · MEDICC Review
7. Derivatization and combination therapy of current COVID-19 therapeutic agents: a review of mechanistic pathways, adverse effects, and binding sites
   Sally El Kantar, Bilal Nehmeh, Philippe Saad, Gabie Mitri, Celine Estephan, Mohamad A. Mroueh, Elias Akoury, Robin I. Taleb · 2020 · Drug Discovery Today
8. Cancer is associated with coronavirus disease (COVID-19) severity and mortality: A pooled analysis
   Isaac Cheruiyot, Vincent Kipkorir, Brian Ngure, Musa Misiani, Jeremiah K. Munguti · 2020 · The American Journal of Emergency Medicine
9. Clinical laboratory characteristics of severe patients with coronavirus disease 2019 (COVID-19): A systematic review and meta-analysis
   Xiang Li, Zhongmou Xu, Tianyi Wang, Xiang Ming Xu, Haiying Li, Qin Sun, Xinmin Zhou, Gang Chen · 2020 · Clinical Epidemiology and Global Health
10. Cytokine Storm May Not Be the Chief Culprit for the Deterioration of COVID-19
    Yang Gao, Changsong Wang, Kai Kang, Yahui Peng, Yunpeng Luo, Haitao Liu, Wei Zhong Yang, Mingyan Zhao, Kaijiang Yu · 2020 · Viral Immunology
11. Association of Cigarette Smoking, COPD, and Lung Cancer With Expression of SARS-CoV-2 Entry Genes in Human Airway Epithelial Cells
    Junping Yin, Brigitte Kasper, Frank Petersen, Xinhua Yu · 2020 · Frontiers in Medicine
12. Geographical Variations in Host Predisposition to COVID-19 Related Anosmia, Ageusia, and Neurological Syndromes
    A. Aravin Kumar, Sean Lee, Christine Lock, Nicole Chwee Har Keong · 2021 · Frontiers in Medicine
13. SARS-CoV-2: Origin, Intermediate Host and Allergenicity Features and Hypotheses
    Yuyi Huang, Junmou Xie, Yuhe Guo, Weimin Sun, Ying He, Liu Kequn, Jie Yan, Ailin Tao, Nanshan Zhong · 2021 · Healthcare
14. Multiomic Immunophenotyping of COVID-19 Patients Reveals Early Infection Trajectories
    Yapeng Su, Daniel Chen, Christopher G. Lausted, Dan Yuan, Jongchan Choi, Chengzhen L. Dai, Valentin Voillet, Kelsey Scherler, Pamela Troisch, Venkata R. S. K. Duvvuri et al. · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
15. The Effect of ACE2 Inhibitor MLN-4760 on the Interaction of SARS-CoV-2 Spike Protein with Human ACE2: A Molecular Dynamics Study
    Babak Nami, Avrin Ghanaeian, Kasra Ghanaeian, Negin Nami · 2020 · ChemRxiv
16. Current pharmacological modalities for management of novel coronavirus disease 2019 (COVID‐19) and the rationale for their utilization: A review
    Richard Giovane, Shadi Rezai, Ellen Cleland, Cassandra E. Henderson · 2020 · Reviews in Medical Virology
17. Are Patients with Asthma and Chronic Obstructive Pulmonary Disease Preferred Targets of COVID-19?
    Belaïd Bouazza, Dihia Hadj-Said, Karen A. Pescatore, Rachid Chahed · 2020 · Tuberculosis & respiratory diseases
18. Clinical Efficacy and Safety of Antiviral Drugs in the Extended Use against COVID-19: What We Know So Far
    Md. Jamal Hossain, Tabassum Jannat, Shejuti Rahman Brishty, Urmi Roy, Saikat Mitra, Md. Oliullah Rafi, Md. Rabiul Islam, Mst. Luthfun Nesa, Md. Rabiul Islam, Talha Bin Emran · 2021 · Biologics
19. Survey on COVID‑19‑related mortality associated with occupational infection during the first phase of the pandemic: A systematic review
    Paola Senia, Francesca Vella, Nicola Mucci, George Dounias, Antonio Trovato, Andrea Marconi, Caterina Ledda, Venerando Rapisarda, Ermanno Vitale · 2021 · Experimental and Therapeutic Medicine
20. Prevalence of comorbidities and symptoms stratified by severity of illness amongst adult patients with COVID-19: a systematic review
    Ritambhara Pandey, Devesh Rai, Muhammad Tahir, Abdul Wahab, Dhrubajyoti Bandyopadhyay, Emil Patrick Lesho, Maryrose R Laguio-Vila, Emilio Fentanes, Raseen Tariq, Srihari S. Naidu et al. · 2022 · Archives of Medical Science - Atherosclerotic Diseases
21. COVID-19 fatality rates in hospitalized patients: A new systematic review and meta-analysis
    Alexandre Baptista, Ana Margarida Vieira, Eunice Capela, Pedro Lobo Julião, Ana Macedo · 2023 · Journal of Infection and Public Health
22. Therapeutic Potential of Bioactive Compounds from Edible Mushrooms to Attenuate SARS-CoV-2 Infection and Some Complications of Coronavirus Disease (COVID-19)
    Paran Baruah, Aparup Patra, Sagar Barge, Mojibur R. Khan, Ashis Kumar Mukherjee · 2023 · Journal of Fungi
23. Plaque Reduction Neutralization Test (PRNT) Accuracy in Evaluating Humoral Immune Response to SARS-CoV-2
    Ingrid Siciliano Horbach, Adriana de Souza Azevedo, Waleska Dias Schwarcz, Nathalia dos Santos Alves, Brenda de Moura Dias, Bruno Pimenta Setatino, Luma da Cruz Moura, Ariane Faria de Souza, Caio Bidueira Denani, Stephanie Almeida da Silva et al. · 2024 · Diseases
24. A Review on Currently Available Potential Therapeutic Options for COVID-19
    Solmaz Ohadian Moghadam · 2020 · International Journal of General Medicine
25. Coalescence of co-infection and antimicrobial resistance with SARS-CoV-2 infection: The blues of post-COVID-19 world
    Payal Mazumder, Ajay S. Kalamdhad, Tushara Chaminda, Manish Kumar · 2021 · Case Studies in Chemical and Environmental Engineering
26. A retrospective cohort study of 238,000 COVID-19 hospitalizations and deaths in Brazil
    Marcos Felipe Falcão Sobral, Antônio Roazzi, Ana Iza Gomes da Penha Sobral, Brigitte Renata Bezerra de Oliveira, Gisléia Benini Duarte, Jadson Freire da Silva, Renata Maria Toscano Barreto Lyra Nogueira · 2022 · Scientific Reports
27. T-Cell Subsets and Interleukin-10 Levels Are Predictors of Severity and Mortality in COVID-19: A Systematic Review and Meta-Analysis
    Amal F. Alshammary, Jawaher Alsughayyir, Khalid Khalaf Alharbi, Abdulrahman M. Alsulaiman, Haifa F. Alshammary, Heba Alshammary · 2022 · Frontiers in Medicine
28. Association of cigarette smoking, obesity, and underlying medical conditions with COVID-19 hospitalization and mortality in Iran: A nationwide retrospective ecological study
    Zahra Khorrami, Sairan Nili, Hamid Pour Sharifi, Sana Eybpoosh, Mostafa Shokoohi · 2020 · Medical Journal of the Islamic Republic of Iran
29. A comparative study on bacterial co-infections and prevalence of multidrug-resistant organisms among patients in COVID and non-COVID Intensive Care Units
    Ravichandran Sathyakamala, Alice Peace Daniel, Priyadarshini Shanmugam · 2021 · Journal of preventive medicine and hygiene
30. Antimicrobial Materials: New Strategies to Tackle Various Pandemics
    Samarjeet Singh Siwal, Qibo Zhang, Adesh Kumar Saini, Vijay Kumar Thakur · 2020 · JOURNAL OF RENEWABLE MATERIALS
31. Abnormal Liver Function Tests of Patients with Coronavirus Disease 2019 in Mainland China: A Systematic Review and Meta- Analysis
    Shengliang Xin, Jinghang Xu, Yanyan Yu · 2020 · Journal of Gastrointestinal and Liver Diseases
32. Influenza Virus Entry inhibitors
    Jie Wu Yang, Shuwen Liu · 2022 · Advances in experimental medicine and biology
33. Druggable targets and therapeutic development for COVID-19
    Xiaohua Duan, Lauretta A. Lacko, Shuibing Chen · 2022 · Frontiers in Chemistry
34. MnFe2O4 nanoparticles coated on one-dimensional carbon nanowires derived from Nitrilotriacetic acid as efficient catalysts to activate peroxymonosulfate for moxifloxacin degradation
    Xuefeng Zhang, Yujie Zhang, Qin Yang, Yingchun Yang, Xuping Sun · 2023 · Journal of Industrial and Engineering Chemistry
35. Community-acquired bacterial coinfections and COVID-19
    Michael John Patton, Amit Gaggar, Matthew Might, Nathaniel B. Erdmann, Carlos Javier Orihuela, Kevin S. Harrod · 2023 · Physiological Reviews
36. Chloroquine Inhibits the Release of Inflammatory Cytokines by Human Lung Explants
    Stanislas Grassin‐Delyle, Hélène Salvator, Marion Brollo, Émilie Catherinot, Édouard Sage, Louis‐Jean Couderc, Emmanuel Naline, Philippe Devillier · 2020 · Clinical Infectious Diseases
37. East–West differences in clinical manifestations of COVID‐19 patients: A systematic literature review and meta‐analysis
    Xiucheng Liu, Xiang Li, Teng Sun, Hao Qin, Yeqing Zhou, Chenghang Zou, Junli Cao, Hao Zhang · 2020 · Journal of Medical Virology
38. Cellular and Molecular Immunology Approaches for the Development of Immunotherapies against the New Coronavirus (SARS‐CoV‐2): Challenges to Near‐Future Breakthroughs
    Juliana Gil Melgaço, Danielle Brito e Cunha, Tamiris Azamor, Andréa Marques Vieira da Silva, Luciana Neves Tubarão, Rafael Braga Gonçalves, Robson Q. Monteiro, Sotiris Missailidis, Patrícia Neves, Ana Paula Dinis Ano Bom · 2020 · Journal of Immunology Research
39. Famotidine Repurposing for Novel Corona Virus Disease of 2019: A Systematic Review
    Santenna Chenchula, Avik Ray, Balakrishnan Sadasivam · 2021 · Drug Research
40. Therapeutic potential of mesenchymal stem cells in multiple organs affected by COVID-19
    Gustavo Claudino Paris, Aline de Azevedo, Adriana Lúcia Pires Ferreira, Yanca Maiara A. De Azevedo, Mateus de Almeida Rainho, Genilza Pereira de Oliveira, Karina R. Silva, Erika Afonso Costa Cortez, Ana Carolina Stumbo, Simone Nunes de Carvalho et al. · 2021 · Life Sciences
41. Role of Serum Amyloid A as a Biomarker for Predicting the Severity and Prognosis of COVID-19
    Amal Ahmed Abbas, Asma Alghamdi, Sonia Mezghani, Mourad Ben Ayed, Ahmed M Alamori, Ghazi A. Alghamdi, Wail Bajhmom, Hanan Wajeeh, Salma S. Almutairi, Wafaa M. Radwan · 2022 · Journal of Immunology Research
42. The Role of Exosomes in the Treatment, Prevention, Diagnosis, and Pathogenesis of COVID-19
    Elke Zani‐Ruttenstock, Lina Antounians, Kasra Khalaj, Rebeca Lopes Figueira, Augusto Zani · 2021 · European Journal of Pediatric Surgery
43. Beneficial effect of corticosteroids in severe COVID-19 pneumonia: a propensity score matching analysis
    Tomasz Chroboczek, Marie Lacoste, Chloé Wackenheim, Thibaut Challan-Belval, Benjamin Amar, Thomas Boisson, Jason Hubac, Dominique Leduc, Colleen Masse, Victor Dechaene et al. · 2020 · medRxiv
44. Treatments in the COVID-19 pandemic: an update on clinical trials
    Yanyi Tao, Liang V. Tang, Yu Hu · 2020 · Expert Opinion on Emerging Drugs
45. Is liver involvement overestimated in COVID-19 patients? A meta-analysis
    Gang Li, Yi Yang, Danyang Gao, Yongxing Xu, Jianwen Gu, Pengfei Liu · 2021 · International Journal of Medical Sciences
46. A Retrospective Analysis of the Bacterial Infections, Antibiotic Use, and Mortality Predictors of COVID-19 Patients
    I Wayan Suranadi, Made Agus Kresna Sucandra, Ni Nengah Dwi Fatmawati, Ayu Dilia Febriani Wisnawa · 2022 · International Journal of General Medicine
47. Cytokine storm–based mechanisms for extrapulmonary manifestations of SARS-CoV-2 infection
    Maria Del Nogal Avila, Ranjan Das, Joubert Banjop Kharlyngdoh, Eduardo Molina‐Jijón, Hector Donoro Blazquez, Stéphanie Gambut, Michael Crowley, David K. Crossman, Rasheed A Gbadagesin, Sunveer S. Chugh et al. · 2023 · JCI Insight
48. Correlation between Hepatocyte Growth Factor (HGF) with D-Dimer and Interleukin-6 as Prognostic Markers of Coagulation and Inflammation in Long COVID-19 Survivors
    Bena Zaira, Trilis Yulianti, Jutti Levita · 2023 · Current Issues in Molecular Biology
49. Oral microbiota and respiratory diseases: advances and perspectives
    Xiaohao Liu, Fengxiang Shi, Jiawei Zeng, Jiaming Bi, Chuzi Mo, Yan Chai, Buling Wu, Shuaimei Xu · 2025 · Clinical Microbiology Reviews
50. Immunological map in COVID-19
    Chung-Hsiang Li, Hsin-Ying Clair Chiou, Ming‐Hong Lin, Chang‐Hung Kuo, Yu‐Chih Lin, Yi-Ching Lin, Chih‐Hsing Hung, Chao‐Hung Kuo · 2021 · Journal of Microbiology Immunology and Infection
51. Comparison of comorbidities among severe and non‐severe COVID‐19 patients in Asian versus non‐Asian populations: A systematic review and meta‐analysis
    Anju Puri, Lin He, Mohan Giri, Chengfei Wu, Qinghua Zhao · 2021 · Nursing Open
52. Bacterial coinfections in COVID: Prevalence, antibiotic sensitivity patterns and clinical outcomes from a tertiary institute of Northern India
    Ashutosh Pathak, Sweta Singh, Sanjay Singh, Sanjay Kumar Singh, Nida Fatima, Atul Garg, Ujjala Ghoshal, Chinmoy Sahu · 2022 · Journal of Family Medicine and Primary Care
53. Role of interleukin-6 in coronavirus disease 2019 pneumonia: sensitive marker of inflammation, a predictor of ventilatory support and early marker of post-coronavirus disease lung fibrosis. A single center experience
    Shital Vishnu Patil, Gajanan Gondhali, Abhijit Acharya · 2023 · Egyptian Journal of Chest Diseases and Tuberculosis
54. Repurposing of drugs for COVID-19: a systematic review and meta-analysis
    Pinky Kotecha, Alexander Light, Enrico Checcucci, Daniele Amparore, Cristian Fiori, Francesco Porpiglia, Prokar Dasgupta A, Oussama Elhage · 2021 · Panminerva Medica
55. Secondary pulmonary infection and co-infection in elderly COVID-19 patients during the pandemics in a tertiary general hospital in Beijing, China
    Chaoe Zhou, Yaping Jiang, Li‐Ying Sun, Haixia Li, Xinmin Liu, Lei Huang · 2023 · Frontiers in Microbiology
56. From Emergence to Endemicity: A Comprehensive Review of COVID-19
    Roopa Naik, Sreekant Avula, Sujith Kumar Palleti, Jyotsna Gummadi, Rajarajeshwari Ramachandran, Deepak Chandramohan, Gagandeep S. Dhillon, Angad Singh Gill, Kapil Paiwal, Bushra Firdous Shaik et al. · 2023 · Cureus
57. C-reactive protein-to-lymphocyte ratio is a reliable marker in patients with COVID-19 infection: the CLEAR COVID study
    Burçin Meryem Atak Tel, Gizem Kahveci, Gülali Aktaş, Muhammed Emin Demirkol, Özge Kurtkulağı, Satılmış Bilgin, Tuba Taslamacıoğlu Duman · 2024 · Cirugía y Cirujanos (English Edition)
58. COVID‐19 in Neonates: A Review
    Maryam Saeedi, Razieh Sangsari, Kayvan Mirnia · 2020 · Iranian Journal of Pediatrics
59. Gastrointestinal and renal complications in SARS‐CoV‐2‐infected patients: Role of immune system
    Fatemeh Maghool, Ali Valiani, Tahereh Safari, Mohammad Hassan Emami, Samane Mohammadzadeh · 2020 · Scandinavian Journal of Immunology
60. Chloroquine Analogs: An Overview of Natural and Synthetic Quinolines as Broad Spectrum Antiviral Agents
    Pallaval Veera Bramhachari, Manasa Kanithi, Sangeetha Meenakshisundaram, Achanta Jagadeesh, Alavala Matta Reddy, Thanigaimalai Pillaiyar, Manoj Manickam, Bojjibabu Chidipi · 2020 · Current Pharmaceutical Design
61. A retrospective comparison of drugs against COVID-19
    Jiahong Tan, Yuan Yuan, Xu Cheng, Chunyan Song, Dan Liu, Ding Ma, Qinglei Gao · 2020 · Virus Research
62. Determining available strategies for prevention and therapy: Exploring COVID‑19 from the perspective of ACE2 (Review)
    Liyang Cai, Guo Xi, Yuchen Cao, Peixi Ying, Libing Hong, Yuxi Zhang, Guoguo Yi, Min Fu · 2021 · International Journal of Molecular Medicine
63. Update on Immunology of COVID-19 Disease and Potential Strategy for Controlling.
    Neda K. Dezfuli, Ian Michael Adcock, Nooshin Montazami, Esmaeil Mortaz, Ali Akbar Velayati · 2020 · PubMed Central
64. Repurposed drug against COVID-19: nanomedicine as an approach for finding new hope in old medicines
    Mohammad Zaki Ahmad, Javed Ahmad, Mohammed Aslam, Mohammad Ahmed Khan, Mohammed Yahia Alasmary, Basel A. Abdel‐Wahab · 2021 · Nano Express
65. Association of Clinical and Immunological Characteristics With Disease Severity and Outcomes in 211 Patients With COVID-19 in Wuhan, China
    Man Wang, Yongzhen Fan, Yuqiong Chai, Wenlin Cheng, Kun Wang, Jianlei Cao, Xiaorong Hu · 2021 · Frontiers in Cellular and Infection Microbiology
66. The interaction of the severe acute respiratory syndrome coronavirus 2 spike protein with drug-inhibited angiotensin converting enzyme 2 studied by molecular dynamics simulation
    Babak Nami, Avrin Ghanaeian, Kasra Ghanaeian, Rozhin Houri, Negin Nami, Armin Ghasemi-Dizgah, Oana Caluseriu · 2021 · Journal of Hypertension
67. Global Effect of COVID-19 Pandemic on Cancer Patients and its Treatment: A Systematic Review
    Mohammad Ali, Shahid Ud Din Wani, Mubashir Hussain Masoodi, Nisar Ahmad Khan, Hosakote Gurumallappa Shivakumar, Riyaz Ali M. Osmani, Khalid Ahmed Khan · 2022 · Clinical Complementary Medicine and Pharmacology
68. Coagulopathy and Brain Injury Pathogenesis in Post-Covid-19 Syndrome
    Basheer Abdullah Marzoog · 2022 · Cardiovascular & Hematological Agents in Medicinal Chemistry
69. Potential mechanism of SARS‐CoV ‐2‐associated central and peripheral nervous system impairment
    Yan Zhang, Xue Chen, Lin Jia, Yulin Zhang · 2022 · Acta Neurologica Scandinavica
70. COVID-19: A state of art on immunological responses, mutations, and treatment modalities in riposte
    Xiaolong Gong, Amber Khan, Mohmmad Younus Wani, Aijaz Ahmad, Adriano Gianmaria Duse · 2022 · Journal of Infection and Public Health
71. Pathogen Distribution, Drug Resistance Risk Factors, and Construction of Risk Prediction Model for Drug-Resistant Bacterial Infection in Hospitalized Patients at the Respiratory Department During the COVID-19 Pandemic
    Xiaolin Wei, Qianglin Zeng, Min XIE, Yong Bao · 2023 · Infection and Drug Resistance
72. SARS-CoV-2 and the sympathetic immune response: Dampening inflammation with antihypertensive drugs (Clonidine and Propranolol)
    Sanjiv K. Hyoju, Olga Y. Zaborina, Harry van Goor · 2020 · Medical Hypotheses
73. Emergency room comprehensive assessment of demographic, radiological, laboratory and clinical data of patients with COVID-19: determination of its prognostic value for in-hospital mortality
    Marco Gatti, Marco Calandri, Andrea Biondo, Carlotta Geninatti, Clara Piatti, Irene Ruggirello, Ambra Santonocito, Sara Varello, Laura Bergamasco, Paolo Bironzo et al. · 2021 · Internal and Emergency Medicine
74. Clinical Characteristics and Risk Factors for Severe Outcomes of Novel Coronavirus Infection, January–March 2020, Japan
    Yuuki Tsuchihashi, Yuzo Arima, Takuri Takahashi, Kazuhiko Kanou, Yusuke Kobayashi, Tomimasa Sunagawa, Motoi Suzuki · 2021 · Journal of Epidemiology
75. COVID-19 in the nervous system: physiopathology and neurological manifestations
    Valder Cavalcante Maia Mendonça Filho, Amanda Gomes de Oliveira, Isabelle de Fátima Vieira Camelo Maia, Ananda Carolina Moraes de Falcone, Beatriz Gioppo Betini, Lucas Bruno Rezende, Fernando Henrique Magri Alves · 2023 · Arquivos de Neuro-Psiquiatria
76. Medication therapy strategies for the coronavirus disease 2019 (COVID-19): recent progress and challenges
    Xiaolei Yang, Ye Liu, Yuping Liu, Qing Yang, Xubo Wu, Xuan Huang, Huijia Liu, Weimin Cai, Guo Ma · 2020 · Expert Review of Clinical Pharmacology
77. Extrapulmonary manifestations and complications of severe acute respiratory syndrome coronavirus-2 infection: a systematic review
    Jiacai Cho, Joanne Lee, Ching‐Hui Sia, Chieh Sian Koo, Benjamin YQ Tan, Wei-Zhen Hong, Ellie Ci-En Choi, Xueying Goh, Louis Yi Ann Chai, NishaSuyien Chandran et al. · 2021 · Singapore Medical Journal
78. Herb-Drug Interaction Between Xiyanping Injection and Lopinavir/Ritonavir, Two Agents Used in COVID-19 Pharmacotherapy
    Linhu Ye, Lei Cheng, Yan Deng, Hong Liu, Xinyu Wu, Tingting Wang, Qi Chang, Yan Zhang, Dan Wang, Zongze Li et al. · 2021 · Frontiers in Pharmacology
79. Efficacy and safety of Guduchighana Vati in asymptomatic and mild-to-moderate cases of coronavirus disease-19: A randomized controlled pilot study
    AmitKumar Rai, Umesh Shukla, Nitin Ujjaliya, Pankaj Kumar Gupta, Vivek Khare, Babita Yadav, Amin Hetalben, Rakesh Kumar Rana, Arunabh Tripathi, Shruti Khanduri et al. · 2020 · AYU (An International Quarterly Journal of Research in Ayurveda)
80. Remdesivir Efficacy and Tolerability in Children with COVID-19-Associated Allergic Comorbidities such as Asthma, Allergic Rhinitis, and Atopic Dermatitis
    Gheorghiță Jugulete, Monica Luminița Luminos, Carmen Pavelescu, Mădălina Maria Merişescu · 2023 · Children
81. Fungal–Bacterial Co-Infections and Super-Infections among Hospitalized COVID-19 Patients: A Systematic Review
    Farkad Bantun · 2023 · Journal of Fungi
82. Prediction of tsunami of resistance to some antibiotics is not far‐fetched which used during COVID‐19 pandemic
    Mandana Hosseini, Mohammed Ahmed Hamad, Golazin Mohseni, Shakiba Salamy, Shabnam Dehghan Tarzjani, Majid Taati Moghadam · 2023 · Journal of Clinical Laboratory Analysis
83. Severity and risk of COVID ‐19 in cancer patients: An evidence‐based learning
    Akanksha Manmohan Sharma, Rishabha Malviya, Vinod Kumar, Ramji Gupta, Rajendra Awasthi · 2020 · Dermatologic Therapy
84. Epidemiological and Clinical Characteristics of COVID-19 Patients Studied by Jiroft University of Medical Sciences: Southeast of Iran
    Esmat Rezabeigi-Davarani, Saied Bokaie, Vahid Mashayekhi, Laleh Sharifi, Reza Faryabi, Shohreh Alian Samakkhah, Ahad Ashrafi‐Asgarabad, Kiavash Hushmandi, Mehdi Raei, Salman Daneshi · 2021 · Journal of Advances in Medical and Biomedical Research
85. Potential role of Nigella sativa supplementation with physical activity in prophylaxis and treatment of COVID-19: a contemporary review
    Hossein Shirvani, Fatemeh Rostamkhani, Ehsan Arabzadeh, Faezeh Mohammadi, Fatemeh Mohammadi · 2021 · Sport Sciences for Health
86. Imagem Cardiovascular e Procedimentos Intervencionistas em Pacientes com Infecção pelo Novo Coronavírus
    Isabela Bispo Santos da Silva Costa, Carlos Eduardo Rochitte, Carlos M. Campos, Sílvio Henrique Barberato, Gláucia Maria Moraes de Oliveira, Marcelo Antônio Cartaxo Queiroga Lopes, César Higa Nomura, Alexandre Abizaid, Giovanni Guido Cerri, Roberto Kalil et al. · 2020 · Arquivos Brasileiros de Cardiologia
87. Patients with Prolonged Positivity of SARS-CoV-2 RNA Benefit from Convalescent Plasma Therapy: A Retrospective Study
    Yongran Wu, Ke Hong, Lianguo Ruan, Xiaobo Yang, Jiancheng Zhang, Jiqian Xu, Shangwen Pan, Lehao Ren, Lü Chen, Chaolin Huang et al. · 2020 · Virologica Sinica
88. Repurposing Immunomodulatory Therapies against Coronavirus Disease 2019 (COVID-19) in the Era of Cardiac Vigilance: A Systematic Review
    Courtney M. Campbell, Avirup Guha, Tamanna Zohra Haque, Tomas G. Neilan, Daniel Addison · 2020 · Journal of Clinical Medicine
89. Digestive symptoms and liver injury in patients with coronavirus disease 2019 ( COVID ‐19): A systematic review with meta‐analysis
    Jian Wan, Xuan Wang, Song Su, Yujie Zhang, Yirong Jin, Yanting Shi, Kaichun Wu, Jie Liang · 2020 · JGH Open
90. Mechanisms of COVID-19 Entry into the Cell: Potential Therapeutic Approaches based on Virus Entry Inhibition in COVID-19 Patients with Underlying Diseases
    Hadis Musavi, Omid Abazari, Mohamad Sadegh Safaee, Atena Variji, Bahare Koohshekan, Fatemeh Kalaki-Jouybari, Zeinab Barartabar, Pejman Hakemi, Soleiman Mahjoub · 2021 · Iranian Journal of Allergy Asthma and Immunology
91. Clostridioides difficile and Vancomycin-Resistant Enterococci in COVID-19 Patients with Severe Pneumonia
    Kateřina Bogdanová, Lenka Doubravská, Iva Vágnerová, Kristýna Hricová, Vendula Pudová, Magdaléna Röderová, Jan Papajk, Radovan Uvízl, Kateřina Langová, Milan Kolář · 2021 · Life
92. A systematic review on immunity functionalities and nutritional food recommendations to develop immunity against viral infection
    Vinay Kumar Pandey, Anjali Tripathi, Shivangi Srivastava, Sneha Pandey, Aamir Hussain Dar, RAHUL KUNWAR SINGH, Prabavathy Duraisamy, Poornima Singh, Ayaz Mukarram Shaikh · 2023 · Applied Food Research
93. Increased serum interleukin-6 and lactate dehydrogenase levels among nonsurvival severe COVID-19 patients when compared to survival ones
    Riham Abdel‐Hamid Haroun, Waleed H. Osman, Rasha Emad Amin, Asmaa M. Eessa, Soha Saad · 2023 · International Immunopharmacology
94. COVID and hematology: special considerations regarding patient safety, gold standard therapies and safety for health care professionals
    Marcia Maiolino Garnica, Ângelo Maiolino · 2020 · Hematology Transfusion and Cell Therapy
95. Pandemic-Related Submissions: The Challenge of Discerning Signal Amidst Noise
    Thomas Pritchett Bleck, Timothy G. Buchman, Richard Phillip Dellinger, Clifford Scott Deutschman, John C. Marshall, David M. Maslove, Henry Masur, Margaret M. Parker, Donald S. Prough, Aarti Sarwal et al. · 2020 · Critical Care Medicine
96. Gastrointestinal Symptoms and Elevation in Liver Enzymes in COVID-19 Infection: A Systematic Review and Meta-Analysis
    Srinivas Reddy Puli, Muhammad Baig, Saqib Walayat · 2020 · Cureus
97. Liver injury with COVID-19 based on gastrointestinal symptoms and pneumonia severity
    Shun Kaneko, Masayuki Kurosaki, Kaoru Nagata, Reiko Taki, Ken Ueda, Satoko Hanada, Koji Takayama, Shinichiro Suzaki, Naoshige Harada, Toru Sugiyama et al. · 2020 · PLoS ONE
98. Projecting COVID-19 disease severity in cancer patients using purposefully-designed machine learning
    Saket Navlakha, Sejal M. Morjaria, Rocío Pérez-Johnston, Allen Zhang, Ying Taur · 2021 · BMC Infectious Diseases
99. Comparison of SARS-CoV-2 Evolution in Paediatric Primary Airway Epithelial Cell Cultures Compared with Vero-Derived Cell Lines
    Connor Bamford, Lindsay Broadbent, Elihú Aranday-Cortés, Mary McCabe, James Patrick McKenna, David Courtney, Olivier Touzelet, Ahlam Ali, Grace C. Roberts, Guillermo López–Campos et al. · 2022 · Viruses
100. Olfactory and Gustatory Dysfunction in 2019 Novel Coronavirus: An Updated Systematic Review and Meta-analysis
     Marzieh Esmaeili, Fatemeh Abdi, Gita Shafiee, Hamid Asayesh, Hamid Asayesh, Fereshteh Baygi, Mostafa Qorbani, Mostafa Qorbani · 2021 · International Journal of Preventive Medicine